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ICommentary
International Commission for Protection
Against Environmental Mutagens and
Carcinogens (ICPEMC)
The International Commission for Protection
against Environmental Mutagens and Carcinogens
(ICPEMC) was founded (1-8) in January of 1977 as
a result of a meeting organized by the Institut de la
Vie in June of 1976. ICPEMC is sponsored by the
Institut de la Vie, and is affiliated with the Interna-
tional Association of Environmental Mutagen
Societies. During its first year the Commission es-
tablished a formal organizational structure and re-
cruited a score of members from academia, re-
search institutes, and industry with extensive ex-
perience in the fields of mutagenesis and car-
cinogenesis: Dr. F. H. Sobels (The Netherlands),
Chairman; Dr. F. J. de Serres (USA), Vice-
Chairman; Dr. P. H. M. Lohman (The Netherlands),
Secretary; Dr. B. E. Matter (Switzerland), Trea-
surer; Dr. M. Marois (France), Vice-Chairman for
liaison; Dr. P. Oftedal (Norway), President IAEMS;
Dr. H. S. Bennett (USA); Dr. N. P. Bochkov
(USSR); Dr. H. Bohme (GDR); Dr. B. A. Bridges
(UK); Dr. J. Clemmesen (Denmark); Dr. J. W.
Drake (USA); Dr. N. P. Dubinin (USSR); Dr. A.
Hollaender (USA); Dr. J. D. Jansen (The Nether-
lands); Dr. C. Ramel (Sweden); Dr. V. Ray (USA);
Dr. R. J. §raim (Czechoslovakia); Dr. T. Sugimura
(Japan); Dr. K. Sundaram (India); Dr. L. Tomatis
(France); Dr. A. C. Upton (USA); Dr. F. Vogel
(FRG).
Mankind suffers every generation from genetic
disease resulting from damage inflicted on the ge-
netic material by natural processes. Increasing
human exposure to numerous man-made chemicals,
many of which are of great benefit to mankind but
some of which are potentially dangerous to human
heredity, raises the question as to what extent man-
kind might be at risk. For instance, it is clear from
laboratory studies that some chemicals do have the
potential to damage human genetic material. It is
also clear that damages in the genetic material are
associated with heritable genetic disease, birth de-
fects and cancer.
The primary objective of ICPEMC is to identify
and promote scientific principles in the fields ofen-
vironmental mutagenesis, carcinogenesis and ge-
netic toxicology. To implement this aim, ICPEMC
will develop statements that may serve as basis for
guidelines and regulations in the national or inter-
national context, with the object of minimizing or
preventing deleterious effects in man due to the in-
teraction ofchemicals with genetic material. Firstly
it will prepare critical evaluations of the current
body of knowledge that may serve as a basis for
establishing priorities for further research or possi-
ble regulatory action. Secondly, substances and
situations will be identified that may entail signifi-
cantgenotoxic hazard to man.
Thorough and time-consuming studies will be
necessary to achieve these tasks. To this end,
ICPEMC has thus far formed five committees,
whose membership is nonoverlapping with that of
the Commission itself. Each Committee is respon-
sible for reviewing a specific area within the next
few years.
Committee 1, chaired by Dr. B. J. Kilbey (UK), is
charged with reviewing the development, valida-
tion, application and comparison of short-term
screening systems foridentifying and characterizing
chemical mutagens. Basically this committee will
select criteria by which to judge the suitability of
any particular testfor use in screeningchemicals for
mutagenesis. Subsequently it will apply these
criteria to the evaluation ofexisting tests as well as
an new ones putforward inthe future.
Co i 'ttee 2, chaired by Dr. D. Clayson (USA),
will study relationships between carcinogens
and mutagens. It will evaluate the validity of the
various short-term genetic tests, their predictive
value for carcinogenicity at both the qualitative and
quantitative levels, and the extent to which they
may replace chronic animalbioassays.
Committee 3, chaired by Dr. E. Poulsen (Den-
mark), will prepare an ongoing registry of national
February 1979 301regulatory principles and actions. It will collect in-
formation on a worldwide basis on guidelines and
legislation in relation to mutagenicity testing of
chemicals.
Committee 4, chaired by Dr. M. F. Lyon (UK), is
charged with the evaluation of risk estimate proce-
dures of mutagenic chemicals and to develop prac-
tical exposure limits. The Committee will use the
extensive work already carried out on the genetic
hazards of radiation as a basis for estimating the
genetic hazards of chemicals. A group of test
chemicals will then be selected and an attempt will
be made to estimate the genetic hazards posed by
these substances on the basis ofthe system used for
radiation.
Committee 5 will shortly be constituted to con-
sider epidemiological approaches to the possible
mutagenic consequences of exposure to environ-
mental agents.
ICPEMC will also establish smaller Task Groups
composed ofCommission members themselves and
charged with the preparation of ICPEMC state-
ments and proposing priorities. To date the following
are already at work:
Task Group 1 will consider and make preliminary
analyses ofchemicals or situations involving a pos-
sible mutagenic risk with a view to presenting to the
Commission a list of high-priority candidates for
further consideration in the Commission and its
Committee.
Task Group 2 will be responsible for developing
recommendations concerning currently optimal
mutagenicity testing strategies. Preliminary propos-
als will be submitted to the Commission in the
Springof 1979.
Task Group 3 is concerned with proposing
specific recommendations for a scientific approach
to the monitoring of populations or groups acci-
dently exposed to large doses of a suspected muta-
gen. This group submitted its first draft proposal to
the Commission in April, 1978. It is expected that
the final statement will be submitted to scientific
journals laterin 1978.
In performing its tasks ICPEMC recognized the
expertise ofother bodies in its fields ofinterest and
seeks to cooperate with them whenever possible.
Liaison with the International Agency for Research
on Cancer (IARC), the International Commission
on Radiation Protection (ICRP), the World Health
Organization (WHO) and the United Nations En-
vironmental Program (UNEP) have already been
initiated.
Contacts and requests for information should be
sent to the Secretary of ICPEMC, Dr. P. H. M.
Lohman, Medical Biological Laboratory TNO,
P. 0. Box 45, 2280 AA Rijswijk. The Netherlands.
P. H. M. LOHMAN
Medical Biological Laboratory
TNO
P. 0. Box 45
2280 4A Rijswvijk
The Netherlands
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